THERABIOGEN, INC. General and Administrative Expense
THERABIOGEN, INC. reported General and Administrative Expense of $300.28 thousand for the 3-month period ending 2012-05-31, per its 10-Q filed 2012-07-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2012-07-23
- THERABIOGEN, INC. general and administrative expense for the quarter ending 2012-05-31 was $300.28K, a 97.40% decline year-over-year.
- THERABIOGEN, INC. general and administrative expense for the quarter ending 2012-02-29 was $664.06K, a 42.59% decline year-over-year.
- THERABIOGEN, INC. general and administrative expense for the quarter ending 2011-11-30 was $705.07K, a 213.88% increase year-over-year.
- THERABIOGEN, INC. general and administrative expense for the quarter ending 2011-08-31 was $521.56K, a 62.17% decline year-over-year.
- THERABIOGEN, INC. general and administrative expense for fiscal 2012 was $13.44M, a 275.25% increase from fiscal 2011.
- THERABIOGEN, INC. general and administrative expense for fiscal 2011 was $3.58M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month | General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2012-05-31 | $300.28K 10-Q · filed 2012-07-23 | $964.34K derived: sum of 2 quarters · filed 2012-07-23 | $1.67M derived: sum of 3 quarters · filed 2012-07-23 | $2.19M derived: sum of 4 quarters · filed 2012-07-23 | |
| 2012-02-29 | $664.06K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-07-18 | $1.37M derived: sum of 2 quarters · filed 2012-07-18 | $1.89M derived: sum of 3 quarters · filed 2012-07-18 | $13.44M 10-K/A · filed 2012-07-18 | $13.41M 10-K · filed 2012-07-16 |
| 2011-11-30 | $705.07K 10-Q · filed 2012-01-17 | $1.23M derived: sum of 2 quarters · filed 2012-01-17 | $12.78M 10-Q · filed 2012-01-17 | $13.93M derived: sum of 4 quarters · filed 2012-07-23 | |
| 2011-08-31 | $521.56K 10-Q/A · filed 2011-11-17 | $12.07M 10-Q/A · filed 2011-11-17 | $13.23M derived: sum of 3 quarters · filed 2012-07-23 | $13.45M derived: sum of 4 quarters · filed 2012-07-23 | |
| 2011-05-31 | $11.55M 10-Q · filed 2012-07-23 | $12.71M derived: sum of 2 quarters · filed 2012-07-23 | $12.93M derived: sum of 3 quarters · filed 2012-07-23 | $14.31M derived: sum of 4 quarters · filed 2012-07-23 | |
| 2011-02-28 | $1.16M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-07-18 | $1.38M derived: sum of 2 quarters · filed 2012-07-18 | $2.76M derived: sum of 3 quarters · filed 2012-07-18 | $3.58M 10-K/A · filed 2012-07-18 | |
| 2010-11-30 | $224.63K 10-Q · filed 2012-01-17 | $1.60M derived: sum of 2 quarters · filed 2012-01-17 | $2.43M 10-Q · filed 2012-01-17 | ||
| 2010-08-31 | $1.38M 10-Q/A · filed 2011-11-17 | $2.20M 10-Q/A · filed 2011-11-17 |